PB2171: POTENTIAL ROLE OF FACTOR XII POLYMORPHISM IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

• Elizaveta Efremova,
• Sergey Kapustin,
• Nadezhda Nemscveridze,
• Anna Pirkhalo,
• Ekaterina Mileeva,
• Natalia Silina,
• Natalia Korsakova,
• Olesia Matvienko,
• Ludmila Papayan,
• Sergey Voloshin

Affiliations

Elizaveta Efremova

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Sergey Kapustin

2 Hospital 31, Biologist, Saint-Petersburg, Russia

Nadezhda Nemscveridze

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Anna Pirkhalo

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Ekaterina Mileeva

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Natalia Silina

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Natalia Korsakova

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Olesia Matvienko

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Ludmila Papayan

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia

Sergey Voloshin

1 Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia